tiprankstipranks
Trending News
More News >
Shield Therapeutics PLC (GB:STX)
LSE:STX
UK Market

Shield Therapeutics (STX) Financial Statements

Compare
41 Followers

Shield Therapeutics Financial Overview

Shield Therapeutics's market cap is currently £111.49M. The company's EPS TTM is p-0.0074615728999999995; its P/E ratio is -5.65; Shield Therapeutics is scheduled to report earnings on August 21, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue£ 25.18M£ 13.09M£ 5.50M£ 1.52M£ 10.39M
Gross Profit£ 10.57M£ 4.03M£ 2.00M£ 539.00K£ 9.03M
Operating Income£ -17.98M£ -31.33M£ -26.39M£ -20.41M£ -2.15M
EBITDA£ -16.58M£ -30.29M£ -46.07M£ -17.69M£ 820.00K
Net Income£ -21.27M£ -33.29M£ -40.44M£ -19.34M£ -2.63M
Balance Sheet
Cash & Short-Term Investments£ 5.61M£ 13.95M£ 2.82M£ 12.12M£ 2.94M
Total Assets£ 45.90M£ 48.80M£ 22.07M£ 44.41M£ 32.53M
Total Debt£ 21.06M£ 20.41M£ 6.10M£ 156.00K£ 28.00K
Net Debt£ 15.45M£ 6.46M£ 3.28M£ -11.96M£ -2.91M
Total Liabilities£ 46.95M£ 26.49M£ 16.65M£ 3.38M£ 2.25M
Stockholders' Equity£ -1.05M£ 11.79M£ 5.43M£ 40.69M£ 30.28M
Cash Flow
Free Cash Flow£ -7.03M£ -40.07M£ -20.14M£ -18.80M£ -1.42M
Operating Cash Flow£ -7.01M£ -37.13M£ -18.25M£ -16.74M£ -1.40M
Investing Cash Flow£ -1.89M£ -2.43M£ -1.70M£ -2.05M£ -20.00K
Financing Cash Flow£ 4.21M£ 49.66M£ 7.71M£ 27.58M£ -47.00K
Currency in GBP

Shield Therapeutics Earnings and Revenue History

Shield Therapeutics Debt to Assets

Shield Therapeutics Cash Flow

Shield Therapeutics Forecast EPS vs Actual EPS